Roles for Autophagy in Esophageal Carcinogenesis: Implications for Improving Patient Outcomes

Area of Science:

• Oncology
• Cell Biology

Background:

• Esophageal cancer, including esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC), has poor survival rates.
• Autophagy is a cellular process crucial for maintaining homeostasis by degrading damaged components.
• Autophagy's role in cancer is context-dependent, with varied implications in different malignancies.

Purpose of the Study:

• To review the current understanding of autophagy in ESCC and EAC.
• To explore autophagy's involvement in esophageal cancer development and progression.
• To discuss autophagy's potential as a therapeutic target in esophageal cancer.

Main Methods:

• Literature review of studies on autophagy in esophageal cancer.
• Analysis of autophagy's role in ESCC and EAC pathogenesis.
• Examination of autophagy markers and their correlation with patient outcomes.
• Synthesis of research on autophagy modulation in esophageal cancer treatment.

Main Results:

• Autophagy exhibits dual roles in esophageal cancer, potentially promoting or suppressing tumor growth depending on the context.
• Specific autophagy molecular markers are associated with patient prognosis in ESCC and EAC.
• Autophagy influences response to various therapies in esophageal cancer.
• Inhibiting autophagy shows promise as a therapeutic strategy.

Conclusions:

• Autophagy is a critical factor in esophageal cancer biology and patient outcomes.
• Targeting autophagy pathways offers a potential avenue for novel esophageal cancer treatments.
• Further research into autophagy modulation is warranted for improving esophageal cancer therapy.